A promotional campaign has sparked a legal dispute between Spark Therapeutics and Bluebird Bio (BLUE) over the use of a single word: spark. As Bluebird works toward winning U.S. regulatory approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback